Shield’ Blood Test for Colorectal Cancer Added to U.S. NCCN Guidelines — Korean Launch Nears

2025.07.15

NGS to Reduce Infectious Disease Diagnosis from 33 Days to 3 — Clinical Application Imminent

2025.07.01

다우바이오메디카, 폐암 치료 모니터링 CTC 액체생검 기술 소개 l Lung Cancer Monitoring with CTC Liquid Biopsy: Dow Biomedica Highlights Innovative Technology"

2025.06.25

다우바이오메디카 “대장암 선별검사 ‘쉴드’ 국내 상용화” ㅣ Dow Biomedica Introduces ‘Shield’ Colorectal Cancer Screening Test to Korean Market

2025.06.17